(Q43969529)

28 November 2017

Prediction of the response to chemoradiation and prognosis in oesophageal squamous cancer (English)

1 reference

28 November 2017

0 references

K Kishi

1

1 reference

28 November 2017

Y Doki

2

1 reference

28 November 2017

H Miyata

3

1 reference

28 November 2017

M Yano

4

1 reference

28 November 2017

T Yasuda

5

1 reference

28 November 2017

M Monden

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

British Journal of Surgery

28 November 2017

1 reference

28 November 2017

89

1 reference

28 November 2017

5

1 reference

28 November 2017

597-603

1 reference

Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy followed by surgery for T4 squamous cell carcinoma of the esophagus.

28 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02057.X

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02057.X

p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02057.X

p53 is required for radiation-induced apoptosis in mouse thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02057.X

Dephosphorylation of human p34cdc2 kinase on both Thr-14 and Tyr-15 by human cdc25B phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02057.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02057.X

The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02057.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02057.X

Linkage of ATM to cell cycle regulation by the Chk2 protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02057.X

CDC25 phosphatases as potential human oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02057.X

Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: Evidence for multiple roles of mitotic cyclins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02057.X

Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02057.X

Overexpression of metallothionein confers resistance to anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02057.X

p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02057.X

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02057.X

UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02057.X

10.1046/J.1365-2168.2002.02057.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference